GlucoTrack (GCTK) Stock: Buy, Sell, or Hold?
GCTK - GlucoTrack, Inc. Common Stock
$2.55
-0.68 (-21.05%)
▼
5d:
-23.19%
30d:
+576.75%
90d:
+521.95%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When GCTK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: GCTK is down 23.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: GCTK is down 23.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: GCTK is currently trading at $2.55, which is considered slightly high relative to its 30-day fair value range of $-0.09 to $2.65.
Technical Outlook: Technically, GCTK is in a uptrend. Immediate support is located at $0.28, while resistance sits at $4.36. Short-term momentum is weak, with the stock down 21.1% recently.
Market Sentiment: GCTK scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GCTK is in a uptrend. Immediate support is located at $0.28, while resistance sits at $4.36. Short-term momentum is weak, with the stock down 21.1% recently.
Market Sentiment: GCTK scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$-0.09 -
$2.65
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
29.4%
All Signals
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-21.1%)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$-0.09 -
$2.65
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.28
Resistance Level
$4.36
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Share & Embed Analysis
Last updated: September 12, 2026 9:39 AM ET
Data refreshes hourly during market hours. Next update: 10:39 AM
Data refreshes hourly during market hours. Next update: 10:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GCTK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$108 | 50 HOLD |
